Trials / Not Yet Recruiting
Not Yet RecruitingNCT06916130
A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A
A Randomized, Open-label, Multiple Oral-dose, 2x2 Crossover Clinical Trial to Compare the Safety, Pharmacokinetic, and Pharmacodynamic Characteristics of a AD-120 and AD-120A in Healthy Adult Volunteers
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Addpharma Inc. · Industry
- Sex
- All
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Primary endpoint of this study is to evaluate the pharmacokinetic and pharmacodynamic characteristics of AD-120 in healthy subjects.
Detailed description
The purpose of this study is to evaluate the pharmacokinetic and pharmacodynamic characteristics and safety profiles of AD-120 compared with AD-120A in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AD-120A | Administered before the breakfast during 7 days, Oral, Tablet |
| DRUG | AD-120 | Administered before the breakfast during 7 days, Oral, Tablet |
Timeline
- Start date
- 2025-04-21
- Primary completion
- 2025-09-01
- Completion
- 2025-09-01
- First posted
- 2025-04-08
- Last updated
- 2025-04-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06916130. Inclusion in this directory is not an endorsement.